---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-042844"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2026-09-16T12:45:13+00:00"
generated_at: "2026-09-16T12:50:07.740097+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics, ReadyGo collaborate on blood-based PCR testing, starting with Ebola

## Summary
- Collaboration to test ReadyGo's GoCollect sample-prep with Co-Dx PCR platform for blood-based molecular testing at point of need.
- Initial focus on decentralized Ebola detection; WHO cites 6,757 confirmed cases, 3,267 deaths in DRC outbreak as of Sept 7, 2026.
- Feasibility work underway; no compatibility established yet; Co-Dx PCR platform not FDA cleared or available for sale.
- Success could expand platform to bloodborne pathogens including HIV and hepatitis B/C, representing larger markets than current swab menu.

## SEC filing metadata
- accession: 0001493152-26-042844
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2026-09-16T12:45:13+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315226042844/0001493152-26-042844-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315226042844/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-042844
- JSON: https://secwatch.observer/filing/0001493152-26-042844.json
- Plain text: https://secwatch.observer/filing/0001493152-26-042844.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.